Invalda INVL reported equity of EUR 256.2 million by the end of 2025, or EUR 21.25 per share. These figures were 22.1% and 21.8% higher, respectively, than a year ago, including the dividends paid out last year. In 2025 Invalda INVL earned an audited net profit of EUR 47.1 million – 6.1% more compared to the previous year’s profit of EUR 44.4 million. Following these strong results, the company’s board will propose that shareholders approve a dividend distribution of nearly EUR 12.1 million, or EUR 1.0 per share. The final decision on dividends will be taken at the General Meeting of Shareholders on 30 April. “We are living in a period when geopolitical and economic uncertainty has become a new reality. Therefore, consistent teamwork, the ability to adapt to ongoing changes and seize emerging opportunities, decision-making...

• Plan to resume enrollment in clinical study of lorigerlimab in gynecologic cancers   • On track to provide mid-2026 program update  ROCKVILLE, MD, April 08, 2026 (GLOBE NEWSWIRE) — MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that the U. S. Food and Drug Administration (FDA) has removed the partial clinical hold on the Company’s Phase 2 LINNET study of lorigerlimab, an investigational, bispecific DART® molecule that targets PD-1 and CTLA-4. During the partial clinical hold, previously enrolled study participants were allowed to continue to receive study drug. Going forward, new participants will be enrolled under a revised protocol that includes additional risk-mitigation measures for potential...

GREELEY, Colo., April 08, 2026 (GLOBE NEWSWIRE) — Pilgrim’s Pride Corporation (NASDAQ: PPC) announced today that it will release its first quarter 2026 financial results after the U.S. market closes on Wednesday, April 29. The company’s executives will review the results on a conference call and webcast on Thursday, April 30, 2026, at 7:00 a.m. MT (9:00 a.m. ET). Prepared remarks regarding the company’s financial and operational results will be followed by a question and answer period with the Pilgrim’s executive management team. A press release and supplemental materials will be issued before the market opens that morning. Investors and analysts may pre-register for the webcast to receive a unique PIN to gain immediate access to the call and bypass the live operator. Pre-registration may be completed at any time, including up to...

DAVIDSON, N.C., April 08, 2026 (GLOBE NEWSWIRE) — Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, will issue its first quarter 2026 earnings release after the market closes on Tuesday, April 28, 2026. Ingersoll Rand will also host a live earnings conference call to discuss the first quarter results on Wednesday, April 29, 2026, at 8 a.m. Eastern Time. To participate in the call, please dial +1-888-330-3073, domestically, or +1-646-960-0683, internationally, and use access code 8970061. A real-time audio webcast of the presentation can be accessed via the Events and Presentations section of the Ingersoll Rand Investor Relations website here, where related materials will be posted prior to the conference call. A replay of the webcast will be available after...

RAANANA, ISRAEL, April 08, 2026 (GLOBE NEWSWIRE) — Polyrizon Ltd. (NASDAQ: PLRZ) (the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions, today announced the closing of its previously announced registered direct offering and concurrent private placement with a single institutional investor. The Company issued Ordinary Shares and pre-funded warrants in a registered direct offering. In a concurrent private placement, the Company also issued to the same investor pre-funded and investor warrants. Aggregate gross proceeds to the Company from both transactions were approximately $3.5 million. The transactions closed on April 8, 2026. The transactions consisted of the sale of 388,888 Units (or Pre-Funded Units), each consisting of one (1) Ordinary Share (or one (1) Pre-Funded Warrant to purchase...

Notice convening the Annual General Meeting of German High Street Properties A/S Nasdaq OMX CopenhagenCharlottenlund, 8 April 2026Announcement no. 292 The Board of Directors of German High Street Properties A/S (CVR no. 30691644) (the “Company”) hereby convenes the Annual General Meeting to be held on Thursday, 30 April 2026, at 2:00 PM at Søllerødvej 64, 2840 Holte. Agenda:The Board of Directors’ report on the Company’s activities in the past financial year.Proposal by the Board of Directors that annual reports be prepared in English.Presentation of the audited annual report for approval and notification of discharge for the Board of Directors and management.Adoption of the distribution of the result as proposed by the Board of Directors.The Board of Directors’ proposal for board remuneration for 2026.Presentation of the...

Banco Comercial Português, S.A. informs about estimated provisions against legal risk related to FX mortgage loans portfolio booked by Bank Millennium, S.A. in 1Q 2026Attachment2026 04 08 Provisões Polónia EN

OTTAWA, April 08, 2026 (GLOBE NEWSWIRE) — Viridian Metals Inc. (CSE: VRDN) (“Viridian” or the “Company”) reports that it has been awarded $225,000 under the Junior Exploration Assistance (“JEA”) program, representing the maximum funding available through the program for the 2025 cycle. This funding supported the Company’s 2025 field program at its Sedna Project in Labrador. This marks the third consecutive year Viridian has received the maximum JEA award, following funding received for its 2023 and 2024 exploration programs. The Company intends to submit a further application under the program to support planned 2025 work at its Kraken Project. The JEA program provides non-dilutive funding to advance mineral exploration across Newfoundland and Labrador, with a focus on new discovery and progression of projects toward defined mineral...

Press release                                                                                                                               Paris, April 8, 2026 Availability of Credit Agricole Assurances Group’s Solvency and Financial Condition Report for the financial year 2025 Crédit Agricole Assurances announced today the release of its Group Solvency and Financial Condition Report (SFCR) for the financial year 2025. The SFCR was established in accordance with Solvency II regulations. It takes account, in particular, of the guidelines of the European Insurance and Occupational Pensions Authority (EIOPA) and the notices of the Autorité de Contrôle Prudentiel et de Résolution (ACPR) in that respect. The SFCR provides an overview of insurance activities in the Solvency 2 environment. This report, together with the various annual quantitative...

                                                                 Press Release                 Contact e-mail: ag2026@lectra.com Combined Shareholders’ Meeting of April 29, 2026 – Conditions of availability of the preparatory documents Paris, April 8, 2026 – Shareholders of Lectra are invited to participate in the Combined Shareholders’ Meeting which will be held on Wednesday April 29, 2026 at 9:30 a.m. (CET) at InterContinental Paris Champs-Elysées Etoile, 64 avenue Marceau, 75008 Paris. This Combined Shareholders’ Meeting will be broadcast live in full, and a webcast replay will be available via the following link (also available on the Lectra website, on the webpage dedicated to Shareholders’ Meetings):LECTRA – Combined Shareholders’ Meeting of April 29, 2026 (in French and in English)The notice of meeting (avis de...